R. Manjunatha Kini
Corporate Officer/Principal at National University of Singapore
R. Manjunatha Kini active positions
| Companies | Position | Start | End |
|---|---|---|---|
| National University of Singapore | Corporate Officer/Principal | - | - |
Career history of R. Manjunatha Kini
Former positions of R. Manjunatha Kini
| Companies | Position | Start | End |
|---|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Founder | 2005-03-31 | - |
Statistics
International
| Singapore | 3 |
Operational
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- R. Manjunatha Kini
- Experience
